{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T00:04:23Z","timestamp":1790899463046,"version":"4.1.0"},"reference-count":33,"publisher":"BMJ","issue":"2","funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Thorax"],"published-print":{"date-parts":[[2019,2]]},"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>Anaesthesiology guidelines suggest that opioids worsen obstructive sleep apnoea (OSA) despite no randomised controlled trial evidence. We therefore conducted a randomised controlled trial to evaluate the effects of a common clinical dose of morphine on OSA, and to identify clinical phenotype and genotype vulnerability to opioid-respiratory depression.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Under a double-blind, randomised, crossover design, 60 male patients with OSA attended two visits to the hospital sleep laboratory, at least 1\u2009week apart. Either 40\u2009mg controlled-release oral morphine or placebo was administered. Awake ventilatory chemoreflex tests were performed post dose and prior to overnight polysomnography monitoring. Blood was sampled before sleep and the next morning for toxicology and genotype analyses. Sleep time with oxygen saturation (SpO<jats:sub>2<\/jats:sub>) &lt;90% (T90) was the primary outcome.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Despite a large inter-individual variability, 40\u2009mg morphine did not worsen T90 and apnoea\u2013hypopnoea index, and only decreased the SpO<jats:sub>2<\/jats:sub> nadir by 1.3%. In patients with severe OSA, a lower baseline CO<jats:sub>2<\/jats:sub>ventilatory response threshold correlated with the worsening of T90, apnoea\u2013hypopnoea index and oxygen desaturation index with morphine use. Patients with OSA and the A118G OPRM1 polymorphism of A\/A and A\/G had a significantly different morphine effect on awake ventilatory chemosensitivity and T90 during sleep.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>40\u2009mg oral controlled-release morphine did not worsen OSA in men, challenging traditional thinking that OSA will be worsened by opioids. Individual opioid response in patients with OSA may relate to baseline CO<jats:sub>2<\/jats:sub> response threshold and OPRM1 genotype. Our study findings may pave the way for a precision medicine approach to avoid opioid-related risks.<\/jats:p><\/jats:sec><jats:sec><jats:title>Trial registration number<\/jats:title><jats:p>The Australian and New Zealand Clinical Trial Registry, ACTRN12613000858796.<\/jats:p><\/jats:sec>","DOI":"10.1136\/thoraxjnl-2018-211675","type":"journal-article","created":{"date-parts":[[2018,8,30]],"date-time":"2018-08-30T16:23:54Z","timestamp":1535646234000},"page":"177-184","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":32,"title":["The effect of acute morphine on obstructive sleep apnoea: a randomised double-blind placebo-controlled crossover trial"],"prefix":"10.1136","volume":"74","author":[{"given":"Luke","family":"Rowsell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith K H","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brendon J","family":"Yee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danny J","family":"Eckert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew A","family":"Somogyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Duffin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald R","family":"Grunstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2018,8,30]]},"reference":[{"key":"2020050723471180000_74.2.177.1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp1011512"},{"key":"2020050723471180000_74.2.177.2","first-page":"93","article-title":"Unintentional poisoning deaths--United States, 1999-2004","volume":"56","author":"Centers for Disease Control and Prevention (CDC)","year":"2007","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2020050723471180000_74.2.177.3"},{"key":"2020050723471180000_74.2.177.4","unstructured":"Gutstein H , Akil H . Opioid analgesics. In: Hardman JG , Limbird LE , Gilman AG , eds. Goodman and Gilman\u2019s The pharmacological basis of therapeutics. 11th edition. New York: McGraw-Hill, 2005."},{"key":"2020050723471180000_74.2.177.5","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/S2213-2600(15)00043-0","article-title":"Prevalence of sleep-disordered breathing in the general population: the HypnoLaus study","volume":"3","author":"Heinzer","year":"2015","journal-title":"Lancet Respir Med"},{"key":"2020050723471180000_74.2.177.6","doi-asserted-by":"publisher","DOI":"10.1016\/j.sleep.2008.08.007"},{"key":"2020050723471180000_74.2.177.7","doi-asserted-by":"publisher","DOI":"10.1097\/ALN.0000000000000053"},{"key":"2020050723471180000_74.2.177.8","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1213\/ANE.0000000000001416","article-title":"Society of anesthesia and sleep medicine guidelines on preoperative screening and assessment of adult patients with obstructive sleep apnea","volume":"123","author":"Chung","year":"2016","journal-title":"Anesth Analg"},{"key":"2020050723471180000_74.2.177.9","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1213\/ANE.0000000000001178","article-title":"Does obstructive sleep apnea influence perioperative outcome? a qualitative systematic review for the society of anesthesia and sleep medicine task force on preoperative preparation of patients with sleep-disordered breathing","volume":"122","author":"Opperer","year":"2016","journal-title":"Anesth Analg"},{"key":"2020050723471180000_74.2.177.10","doi-asserted-by":"publisher","DOI":"10.1097\/ALN.0000000000000041"},{"key":"2020050723471180000_74.2.177.11","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1097\/ACO.0000000000000265","article-title":"Obstructive sleep apnea, pain, and opioids: is the riddle solved?","volume":"29","author":"Lam","year":"2016","journal-title":"Curr Opin Anaesthesiol"},{"key":"2020050723471180000_74.2.177.12","first-page":"S67","article-title":"American Society of Interventional Pain Physicians (ASIPP) guidelines for responsible opioid prescribing in chronic non-cancer pain: Part 2--guidance","volume":"15","author":"Manchikanti","year":"2012","journal-title":"Pain Physician"},{"key":"2020050723471180000_74.2.177.13","doi-asserted-by":"publisher","DOI":"10.1097\/ALN.0b013e318190b501"},{"key":"2020050723471180000_74.2.177.14","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.resp.2012.11.014","article-title":"The effects of a single mild dose of morphine on chemoreflexes and breathing in obstructive sleep apnea","volume":"185","author":"Wang","year":"2013","journal-title":"Respir Physiol Neurobiol"},{"key":"2020050723471180000_74.2.177.15","doi-asserted-by":"publisher","DOI":"10.1038\/sj.clpt.6100095"},{"key":"2020050723471180000_74.2.177.16","doi-asserted-by":"publisher","DOI":"10.1097\/ALN.0b013e31825a2a4e"},{"key":"2020050723471180000_74.2.177.17","doi-asserted-by":"publisher","DOI":"10.5664\/jcsm.2172"},{"key":"2020050723471180000_74.2.177.18","doi-asserted-by":"publisher","DOI":"10.1016\/S0034-5687(00)00095-5"},{"key":"2020050723471180000_74.2.177.19","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2869.2011.00931.x"},{"key":"2020050723471180000_74.2.177.20","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1111\/pme.12226","article-title":"Single-nucleotide polymorphism C3435T in the ABCB1 gene is associated with opioid consumption in postoperative pain","volume":"14","author":"Candiotti","year":"2013","journal-title":"Pain Med"},{"key":"2020050723471180000_74.2.177.21","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/tpj.2014.59","article-title":"Association of OPRM1 A118G variant with risk of morphine-induced respiratory depression following spine fusion in adolescents","volume":"15","author":"Chidambaran","year":"2015","journal-title":"Pharmacogenomics J"},{"key":"2020050723471180000_74.2.177.22","doi-asserted-by":"crossref","unstructured":"Currow DC , Quinn S , Ekstrom M , et al . Can variability in the effect of opioids on refractory breathlessness be explained by genetic factors? BMJ Open 2015;5:e006818.doi:10.1136\/bmjopen-2014-006818","DOI":"10.1136\/bmjopen-2014-006818"},{"key":"2020050723471180000_74.2.177.23","first-page":"53","article-title":"ABCB1 haplotype and OPRM1 118A > G genotype interaction in methadone maintenance treatment pharmacogenetics","volume":"5","author":"Barratt","year":"2012","journal-title":"Pharmgenomics Pers Med"},{"key":"2020050723471180000_74.2.177.24","doi-asserted-by":"publisher","DOI":"10.1097\/ALN.0000000000000564"},{"key":"2020050723471180000_74.2.177.25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinane.2010.09.003"},{"key":"2020050723471180000_74.2.177.26","doi-asserted-by":"crossref","unstructured":"Timm FP , Zaremba S , Grabitz SD , et al . Effects of opioids given to facilitate mechanical ventilation on sleep apnea after extubation in the intensive care unit. Sleep. In Press. 2018;41.doi:10.1093\/sleep\/zsx191","DOI":"10.1093\/sleep\/zsx191"},{"key":"2020050723471180000_74.2.177.27","first-page":"CD011090","article-title":"Effects of opioid, hypnotic and sedating medications on sleep-disordered breathing in adults with obstructive sleep apnoea","volume":"7","author":"Mason","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"2020050723471180000_74.2.177.28","doi-asserted-by":"publisher","DOI":"10.1152\/japplphysiol.01008.2015"},{"key":"2020050723471180000_74.2.177.29","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201303-0448OC"},{"key":"2020050723471180000_74.2.177.30","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.5665\/sleep.6226","article-title":"The combination of supplemental oxygen and a hypnotic markedly improves obstructive sleep apnea in patients with a mild to moderate upper airway collapsibility","volume":"39","author":"Edwards","year":"2016","journal-title":"Sleep"},{"key":"2020050723471180000_74.2.177.31","doi-asserted-by":"publisher","DOI":"10.1152\/japplphysiol.01208.2003"},{"key":"2020050723471180000_74.2.177.32","doi-asserted-by":"publisher","DOI":"10.1136\/bmjresp-2015-000110"},{"key":"2020050723471180000_74.2.177.33","doi-asserted-by":"publisher","DOI":"10.1378\/chest.128.3.1348"}],"container-title":["Thorax"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/thoraxjnl-2018-211675","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,26]],"date-time":"2020-09-26T06:06:19Z","timestamp":1601100379000},"score":1,"resource":{"primary":{"URL":"https:\/\/thorax.bmj.com\/lookup\/doi\/10.1136\/thoraxjnl-2018-211675"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,30]]},"references-count":33,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2019,1,15]]},"published-print":{"date-parts":[[2019,2]]}},"alternative-id":["10.1136\/thoraxjnl-2018-211675"],"URL":"https:\/\/doi.org\/10.1136\/thoraxjnl-2018-211675","relation":{},"ISSN":["0040-6376","1468-3296"],"issn-type":[{"value":"0040-6376","type":"print"},{"value":"1468-3296","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,30]]}}}